These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 16632357

  • 1. The discovery of tetrahydrofluorenones as a new class of estrogen receptor beta-subtype selective ligands.
    Wilkening RR, Ratcliffe RW, Tynebor EC, Wildonger KJ, Fried AK, Hammond ML, Mosley RT, Fitzgerald PM, Sharma N, McKeever BM, Nilsson S, Carlquist M, Thorsell A, Locco L, Katz R, Frisch K, Birzin ET, Wilkinson HA, Mitra S, Cai S, Hayes EC, Schaeffer JM, Rohrer SP.
    Bioorg Med Chem Lett; 2006 Jul 01; 16(13):3489-94. PubMed ID: 16632357
    [Abstract] [Full Text] [Related]

  • 2. Estrogen receptor beta-subtype selective tetrahydrofluorenones: use of a fused pyrazole as a phenol bioisostere.
    Wilkening RR, Ratcliffe RW, Fried AK, Meng D, Sun W, Colwell L, Lambert S, Greenlee M, Nilsson S, Thorsell A, Mojena M, Tudela C, Frisch K, Chan W, Birzin ET, Rohrer SP, Hammond ML.
    Bioorg Med Chem Lett; 2006 Aug 01; 16(15):3896-901. PubMed ID: 16730987
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tetrahydrofluorenones with conformationally restricted side chains as selective estrogen receptor beta ligands.
    Wildonger KJ, Ratcliffe RW, Mosley RT, Hammond ML, Birzin ET, Rohrer SP.
    Bioorg Med Chem Lett; 2006 Sep 01; 16(17):4462-6. PubMed ID: 16815012
    [Abstract] [Full Text] [Related]

  • 9. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J, Bischoff SF, Buhl T, Floersheim P, Fournier B, Geiser M, Halleux C, Kallen J, Keller H, Ramage P.
    J Med Chem; 2005 Jan 27; 48(2):364-79. PubMed ID: 15658851
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
    Compton DR, Sheng S, Carlson KE, Rebacz NA, Lee IY, Katzenellenbogen BS, Katzenellenbogen JA.
    J Med Chem; 2004 Nov 18; 47(24):5872-93. PubMed ID: 15537344
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.
    Güngör T, Chen Y, Golla R, Ma Z, Corte JR, Northrop JP, Bin B, Dickson JK, Stouch T, Zhou R, Johnson SE, Seethala R, Feyen JH.
    J Med Chem; 2006 Apr 20; 49(8):2440-55. PubMed ID: 16610787
    [Abstract] [Full Text] [Related]

  • 13. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
    Meyers MJ, Sun J, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA.
    J Med Chem; 1999 Jul 01; 42(13):2456-68. PubMed ID: 10395487
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Androstenediol analogs as ER-beta-selective SERMs.
    Blizzard TA, Gude C, Morgan JD, Chan W, Birzin ET, Mojena M, Tudela C, Chen F, Knecht K, Su Q, Kraker B, Mosley RT, Holmes MA, Sharma N, Fitzgerald PM, Rohrer SP, Hammond ML.
    Bioorg Med Chem Lett; 2006 Feb 15; 16(4):834-8. PubMed ID: 16309907
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and biochemical characterization of a series of 17α-perfluoroalkylated estradiols as selective ligands for estrogen receptor α.
    Eignerová B, Sedlák D, Dracínský M, Bartunek P, Kotora M.
    J Med Chem; 2010 Oct 14; 53(19):6947-53. PubMed ID: 20812681
    [Abstract] [Full Text] [Related]

  • 17. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold.
    Richardson TI, Norman BH, Lugar CW, Jones SA, Wang Y, Durbin JD, Krishnan V, Dodge JA.
    Bioorg Med Chem Lett; 2007 Jul 01; 17(13):3570-4. PubMed ID: 17485205
    [Abstract] [Full Text] [Related]

  • 18. Indazole estrogens: highly selective ligands for the estrogen receptor beta.
    De Angelis M, Stossi F, Carlson KA, Katzenellenbogen BS, Katzenellenbogen JA.
    J Med Chem; 2005 Feb 24; 48(4):1132-44. PubMed ID: 15715479
    [Abstract] [Full Text] [Related]

  • 19. Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones.
    McDevitt RE, Malamas MS, Manas ES, Unwalla RJ, Xu ZB, Miller CP, Harris HA.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3137-42. PubMed ID: 15876535
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.